Receptor Elimination by E3 Ubiquitin Ligase Recruitment (REULR): A Targeted Protein Degradation Toolbox

por Siepe, Dirk H., Picton, Lora K., Garcia, K. Christopher
Publicado 2023

Alternate evolutionary histories in the sequence space of an ancient protein

por Starr, Tyler N., Picton, Lora K., Thornton, Joseph W.
Publicado 2017

Induced CD45 Proximity Potentiates Natural Killer Cell Receptor Antagonism

por Ren, Junming, Jo, Yeara, Picton, Lora K., Su, Leon L., Raulet, David H., Garcia, K. Christopher
Publicado 2022

Interleukin-2 superkines by computational design

por Ren, Junming, Chu, Alexander E., Jude, Kevin M., Picton, Lora K., Kare, Aris J., Su, Leon, Montano Romero, Alejandra, Huang, Po-Ssu, Garcia, K. Christopher
Publicado 2022

Synergy of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I–deficient and MHC I(+) tumors

por Wolf, Natalie K., Blaj, Cristina, Picton, Lora K., Snyder, Gail, Zhang, Li, Nicolai, Christopher J., Ndubaku, Chudi O., McWhirter, Sarah M., Garcia, K. Christopher, Raulet, David H.
Publicado 2022

Calibration of cell-intrinsic interleukin-2 response thresholds guides design of a regulatory T cell biased agonist

por Glassman, Caleb R, Su, Leon, Majri-Morrison, Sonia S, Winkelmann, Hauke, Mo, Fei, Li, Peng, Pérez-Cruz, Magdiel, Ho, Peggy P, Koliesnik, Ievgen, Nagy, Nadine, Hnizdilova, Tereza, Picton, Lora K, Kovar, Marek, Bollyky, Paul, Steinman, Lawrence, Meyer, Everett, Piehler, Jacob, Leonard, Warren J, Garcia, K Christopher
Publicado 2021

Potentiating adoptive cell therapy using synthetic IL-9 receptors

por Kalbasi, Anusha, Siurala, Mikko, Su, Leon L., Tariveranmoshabad, Mito, Picton, Lora K., Ravikumar, Pranali, Li, Peng, Lin, Jian-Xin, Escuin-Ordinas, Helena, Da, Tong, Kremer, Sarah V., Sun, Amy L., Castelli, Sofia, Agarwal, Sangya, Scholler, John, Song, Decheng, Rommel, Philipp C., Radaelli, Enrico, Young, Regina M., Leonard, Warren J., Ribas, Antoni, June, Carl H., Garcia, K. Christopher
Publicado 2022

Publisher Correction: Potentiating adoptive cell therapy using synthetic IL-9 receptors

por Kalbasi, Anusha, Siurala, Mikko, Su, Leon L., Tariveranmoshabad, Mito, Picton, Lora K., Ravikumar, Pranali, Li, Peng, Lin, Jian-Xin, Escuin-Ordinas, Helena, Da, Tong, Kremer, Sarah V., Sun, Amy L., Castelli, Sofia, Agarwal, Sangya, Scholler, John, Song, Decheng, Rommel, Philipp C., Radaelli, Enrico, Young, Regina M., Leonard, Warren J., Ribas, Antoni, June, Carl H., Garcia, K. Christopher
Publicado 2022